Cargando…

High expression of FUNDC1 predicts poor prognostic outcomes and is a promising target to improve chemoradiotherapy effects in patients with cervical cancer

FUN14 domain containing 1 (FUNDC1) is an important molecule in receptor‐dependent mitophagy. However, the roles of FUNDC1 in human cancer biology remain unknown. The aim of this study was to explore the expression and roles of FUNDC1 in cervical cancer. Immunohistochemistry and Western blotting were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Hailing, Er, Puchun, Cheng, Jingjing, Chen, Xiuli, Ding, Xiaofeng, Wang, Yuwen, Chen, Xi, Yuan, Zhiyong, Pang, Qingsong, Wang, Ping, Qian, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548885/ https://www.ncbi.nlm.nih.gov/pubmed/28719148 http://dx.doi.org/10.1002/cam4.1112

Ejemplares similares

NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc
por: Wang, Yuwen, et al.
Publicado: (2018)

Concurrent or Sequential Chemoradiotherapy after 3-4 Cycles Induction Chemotherapy for LS-SCLC with Bulky Tumor
por: Zhao, Jingjing, et al.
Publicado: (2020)

Predictive value of EGF and uPAR for chemoradiotherapy response and survival in patients with esophageal squamous cell carcinoma
por: Chen, Xi, et al.
Publicado: (2020)

Chemoradiotherapy-Induced CD4(+) and CD8(+) T-Cell Alterations to Predict Patient Outcomes in Esophageal Squamous Cell Carcinoma
por: Chen, Xi, et al.
Publicado: (2019)

PinX1 suppresses tumorigenesis by negatively regulating telomerase/telomeres in colorectal carcinoma cells and is a promising molecular marker for patient prognosis
por: Qian, Dong, et al.
Publicado: (2016)

Inhibition of PC4 radiosensitizes non‐small cell lung cancer by transcriptionally suppressing XLF
por: Zhang, Tian, et al.
Publicado: (2018)

Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases
por: Wang, Jing, et al.
Publicado: (2020)

A nomogram for predicting brain metastases of EGFR-mutated lung adenocarcinoma patients and estimating the efficacy of therapeutic strategies
por: Wang, Jing, et al.
Publicado: (2021)

The expression of PDGF-BB predicts curative effect in locally advanced esophageal squamous cell carcinoma treated by radiotherapy
por: Er, Puchun, et al.
Publicado: (2020)

FUNDC1: A Promising Mitophagy Regulator at the Mitochondria-Associated Membrane for Cardiovascular Diseases
por: Li, Guoyong, et al.
Publicado: (2021)

Is MPP a good prognostic factor in stage III lung adenocarcinoma with EGFR exon 19 mutation?
por: Zhang, Tian, et al.
Publicado: (2017)

Associations between clinical characteristics and tumor response to neoadjuvant chemoradiotherapy in rectal cancer
por: Pang, Xiaolin, et al.
Publicado: (2021)

Brain metastasis in non-small cell lung cancer (NSCLC) patients with uncommon EGFR mutations: a report of seven cases and literature review
por: Er, Puchun, et al.
Publicado: (2017)

Epithelial–mesenchymal transition, proliferation, and angiogenesis in locally advanced cervical cancer treated with chemoradiotherapy
por: Rojas‐Puentes, Leonardo, et al.
Publicado: (2016)

High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy
por: Mitra, Devarati, et al.
Publicado: (2019)

Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial
por: Chen, Jie, et al.
Publicado: (2022)

Prophylactic Extended-Field Irradiation for Patients With Cervical Cancer Treated With Concurrent Chemoradiotherapy: A Propensity-Score Matching Analysis
por: Wang, Weiping, et al.
Publicado: (2018)

Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy
por: Wang, Yaqi, et al.
Publicado: (2019)

The Emerging Role of FUNDC1-Mediated Mitophagy in Cardiovascular Diseases
por: Liu, Lei, et al.
Publicado: (2021)

Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and Chemoradiotherapy
por: Cheng, Xingyuan, et al.
Publicado: (2023)

Impact of treatment time‐related factors on prognoses and radiation proctitis after definitive chemoradiotherapy for cervical cancer
por: Huang, Eng‐Yen, et al.
Publicado: (2016)

The multi-faced role of FUNDC1 in mitochondrial events and human diseases
por: Tan, Nannan, et al.
Publicado: (2022)

Severe muscle loss during radical chemoradiotherapy for non‐metastatic nasopharyngeal carcinoma predicts poor survival
por: Huang, Xiao, et al.
Publicado: (2019)

Epstein–Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma
por: Xia, Bing, et al.
Publicado: (2019)

Immune correlates of therapy outcomes in women with cervical cancer treated with chemoradiotherapy: A systematic review
por: Lakomy, David S., et al.
Publicado: (2021)

Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma
por: Zhang, Wencheng, et al.
Publicado: (2021)

FUN14 Domain Containing 1 (FUNDC1): A Promising Mitophagy Receptor Regulating Mitochondrial Homeostasis in Cardiovascular Diseases
por: Mao, Yu, et al.
Publicado: (2022)

Platelet-to-lymphocyte ratio is an independent predictor of chemoradiotherapy-related esophageal fistula in esophageal cancer patients
por: Han, Dong, et al.
Publicado: (2020)

FUNDC1: An Emerging Mitochondrial and MAMs Protein for Mitochondrial Quality Control in Heart Diseases
por: Bai, Xizhe, et al.
Publicado: (2023)

High PGAM5 expression induces chemoresistance by enhancing Bcl-xL-mediated anti-apoptotic signaling and predicts poor prognosis in hepatocellular carcinoma patients
por: Cheng, Jingjing, et al.
Publicado: (2018)

Correlation between hematological parameters and outcome in patients with locally advanced cervical cancer treated by concomitant chemoradiotherapy
por: Gennigens, Christine, et al.
Publicado: (2020)

Association Between Bone Marrow Dosimetric Parameters and Acute Hematologic Toxicity in Cervical Cancer Patients Undergoing Concurrent Chemoradiotherapy: Comparison of Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiation Therapy
por: Hui, Beina, et al.
Publicado: (2014)

Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy
por: Zhou, Xi‐Lei, et al.
Publicado: (2019)

The mitophagy receptor FUN14 domain-containing 1 (FUNDC1): A promising biomarker and potential therapeutic target of human diseases
por: Zhang, Weilin
Publicado: (2020)

Randomised clinical trial of a gastrointestinal care bundle to reduce symptoms in patients with pelvic cancer undergoing chemoradiotherapy
por: White, Katherine L, et al.
Publicado: (2020)

Structural insights into the recognition of phosphorylated FUNDC1 by LC3B in mitophagy
por: Lv, Mengqi, et al.
Publicado: (2016)

High expression of sperm-associated antigen 5 correlates with poor survival in ovarian cancer
por: Zhang, Mei, et al.
Publicado: (2020)

Mitochondrial outer membrane protein FUNDC2 promotes ferroptosis and contributes to doxorubicin-induced cardiomyopathy
por: Ta, Na, et al.
Publicado: (2022)

Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer
por: Cooke, S L, et al.
Publicado: (2011)

High lncSNHG15 expression may predict poor cancer prognosis: a meta-analysis based on the PRISMA and the bio-informatics analysis
por: Fang, Shi Xu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dojta2cpkoqfttdseo2amqprj8